Gosia Golda

ORCID: 0000-0002-2520-7193
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Epigenetics and DNA Methylation
  • RNA modifications and cancer
  • Immune Cell Function and Interaction
  • Cancer-related gene regulation
  • Genetic Associations and Epidemiology
  • IL-33, ST2, and ILC Pathways
  • T-cell and B-cell Immunology
  • Eosinophilic Esophagitis
  • Immunotherapy and Immune Responses
  • Health, Environment, Cognitive Aging
  • Immune cells in cancer

University of Würzburg
2023

Wellcome Sanger Institute
2022

Jagiellonian University
2020-2021

Max Planck Institute of Immunobiology and Epigenetics
2021

University of Freiburg
2021

Identifying cellular functions dysregulated by disease-associated variants could implicate novel pathways for drug targeting or modulation in cell therapies. However, follow-up studies can be challenging if disease-relevant types are difficult to sample. Variants associated with immune diseases point toward the role of CD4+ regulatory T cells (Treg cells). We mapped genetic regulation (quantitative trait loci [QTL]) gene expression and chromatin activity Treg cells, we identified 133...

10.1016/j.xgen.2022.100117 article EN cc-by Cell Genomics 2022-04-01

Unlike macrophage networks composed of long-lived tissue-resident cells within specific niches, conventional dendritic (cDCs) that generate a 3D network in lymph nodes (LNs) are short lived and continuously replaced by DC precursors (preDCs) from the bone marrow (BM). Here, we examined whether anatomical niches exist which preDCs differentiate toward immature cDCs. In situ photoconversion Prtn3-based fate-tracking revealed LN medullary cords preferential entry sites for preDCs, serving as...

10.1016/j.immuni.2023.06.020 article EN cc-by-nc-nd Immunity 2023-07-17

Cytosine modifications in DNA such as 5-methylcytosine (5mC) underlie a broad range of developmental processes, maintain cellular lineage specification, and can define or stratify types cancer other diseases. However, the wide variety approaches available to interrogate these has created need for harmonized materials, methods, rigorous benchmarking improve genome-wide methylome sequencing applications clinical basic research. Here, we present multi-platform assessment cross-validated...

10.1186/s13059-021-02529-2 article EN cc-by Genome biology 2021-12-01

Abstract Cytosine modifications in DNA such as 5-methylcytosine (5mC) underlie a broad range of developmental processes, maintain cellular lineage specification, and can define or stratify cancer other diseases. However, the wide variety approaches available to interrogate these has created need for harmonized materials, methods, rigorous benchmarking improve genome-wide methylome sequencing applications clinical basic research. Here, we present multi-platform assessment global resource...

10.1101/2020.12.14.421529 preprint EN cc-by-nc-nd bioRxiv (Cold Spring Harbor Laboratory) 2020-12-14
Coming Soon ...